ASCO

Cancer Immunotherapy the Top Focus at ASCO
CNBC
Fri, 05/31/13 - 12:31 pm
ASCO
immunotherapy
cancer
Bristol-Myers Squibb
Roche
and Merck
ASCO presentations portend future shock of immunotherapy drug prices
Fierce Biotech
Thu, 05/30/13 - 11:37 am
ASCO
drug pricing
immunotherapy
Merck
Bristol-Myers Squibb
3 Stocks to Watch Ahead of ASCO
Motley Fool
Tue, 05/28/13 - 06:28 pm
cancer
ASCO
nivolumab
Bristol-Myers Squibb
idelalisad
Gilead
PEGPH20
Halozyme
pancreatic cancer
ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine
TheStreet.com
Thu, 05/16/13 - 10:38 am
ASCO
lung cancer
vaccines
Oncothyreon
Stimuvax
Merck KGaA
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thu, 05/16/13 - 08:54 am
Gilead
ASCO
JNJ
Pharmacyclics
idelalisab
ibrutinib
CLL
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
ASCO
Arqule
Array Biopharma
Astex
AstraZeneca
Bristol-Myers Squibb
GSK
Curis
Exelixis
Pfizer
Immunogen
Seattle Genetics
Sanofi
Synta
Cancer Drug Targets: The March of the Lemmings
Forbes
Thu, 06/7/12 - 04:58 pm
cancer
ASCO
ASCO Data Suggest Dendreon's Provenge Should Go First
Seeking Alpha
Thu, 06/7/12 - 03:29 pm
Provenge
prostate cancer
Dendreon
ASCO
JNJ
Study of Treanda shows great promise for Teva's drug
Fierce Pharma
Mon, 06/4/12 - 05:46 pm
Teva Pharmaceuticals
Treanda
ASCO
non-Hodgkin's lymphoma
ASCO '12: Ariad Pharma Leukemia Drug Posts Improved Response Rates
TheStreet.com
Mon, 06/4/12 - 10:58 am
ASCO
Ariad Pharma
leukemia
Ponatinib
Johnson & Johnson, Bristol-Myers' Cancer Drugs Grab Spotlight
Minyanville
Mon, 06/4/12 - 10:55 am
JNJ
Bristol-Myers Squibb
ASCO
Zytiga
anti-PD-1 immunotherapy
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Fri, 06/1/12 - 12:28 pm
ASCO
antibody-drug conjugate
Roche
Genentech
Immunogen
T-DM1
Adcetris
Seattle Genetics
ASCO Stocks To Consider This Week
Seeking Alpha
Tue, 05/29/12 - 11:15 am
ASCO
Arena Pharmaceuticals
Vivus
JNJ
Bayer
Onyx
Pharmacyclics
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Mon, 05/28/12 - 11:21 am
ASCO
Synta
Sunesis
Arqule
Cyclacel
Aveo
Bristol-Myers Squibb
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1
Seeking Alpha
Thu, 05/24/12 - 12:53 pm
ASCO
Eli Lilly
Galena Biopharma
Dendreon
Exelixis
CytRx
Array Biopharma
Ariad Pharmaceuticals
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com
Thu, 05/17/12 - 10:35 am
ASCO
Array Biopharma
Exelixis
Pharmacyclics
Onyx
Seattle Genetics
Aveo
Ariad Pharmaceuticals
Arqule
Oncothyreon
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Pfizer, Johnson & Johnson, Ariad, and Medivation in Spotlight at Cancer Meeting
Minyanville
Wed, 05/16/12 - 10:53 am
ASCO
Pfizer
JNJ
Ariad Pharmaceuticals
Medivation
Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade
Seeking Alpha
Tue, 05/15/12 - 12:12 pm
ASCO
Allos
Ariad Pharmaceuticals
Arena Pharmaceuticals
Repligen
Sunesis
An ASCO Bio-Pharma Catalyst Trade With A Promising Leukemia Drug
Seeking Alpha
Wed, 05/9/12 - 10:19 am
leukemia
ASCO
Sunesis
Bristol-Myers Squibb
vosaroxin
Ariad Pharmaceuticals
Sanofi
AML
Novartis

Pages